Abstract
Introduction
The current study aimed to assess whether childhood-onset craniopharyngioma patients suffer from symptoms of apathy, as assessed by patients themselves and their close others. We further analyzed whether apathy scores are related to symptoms of depression.
Methods
Childhood-onset craniopharyngioma patients (n = 35, 16 female, median age = 22) and matched healthy controls (n = 35, 19 female, median age = 21) were asked to complete self-ratings of the Apathy Evaluation Scale, whereas informant-ratings were obtained from their close others. Depression was assessed by self-ratings using the German version of the Center for Epidemiological Studies Depression Scale. As primary outcome measures, self- and informant-rated apathy scores were compared between patients and healthy controls. As secondary outcome measures, differences between self- and informant-rated apathy within the single groups and associations between apathy and depression were analyzed.
Results
Compared to healthy controls, patients displayed significantly higher apathy levels in informant-ratings (medianpatients = 18, mediancontrols = 12, p = .021), but not in self-ratings (medianpatients = 11, mediancontrols =12, p = .68). In patients, there was a significant discrepancy between self- and informant-rated apathy and self-rated apathy was related to symptoms of depression.
Conclusions
This is the first study to show that childhood-onset craniopharyngioma patients may be at high risk for apathy. Noteworthy, apathy levels in the patient group were judged to be high by their close others but not by the patients themselves, indicating that many patients were not fully aware of their impairments. As apathy is associated with numerous adverse outcomes affecting everyday life and vocational opportunities, future investigations are needed to identify specific risk factors for apathy.
Clinical Trial Registration No: NCT00258453.
Similar content being viewed by others
Abbreviations
- CP:
-
Craniopharyngioma
References
Muller HL, Merchant TE, Puget S, Martinez-Barbera JP (2017) New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma. Nat Rev Endocrinol https://doi.org/10.1038/nrendo.2016.217
Muller HL (2016) Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity. Curr Opin Endocrinol Diabetes Obes 23:81–89. https://doi.org/10.1097/MED.0000000000000214
Ozyurt J, Muller HL, Thiel CM (2015) A systematic review of cognitive performance in patients with childhood craniopharyngioma. J Neurooncol 125:9–21. https://doi.org/10.1007/s11060-015-1885-z
Zada G, Kintz N, Pulido M, Amezcua L (2013) Prevalence of neurobehavioral, social, and emotional dysfunction in patients treated for childhood craniopharyngioma: a systematic literature review. PLoS ONE 8:e76562. https://doi.org/10.1371/journal.pone.0076562
Dekkers OM, Biermasz NR, Smit JW, Groot LE, Roelfsema F, Romijn JA, Pereira AM (2006) Quality of life in treated adult craniopharyngioma patients. Eur J Endocrinol 154:483–489. https://doi.org/10.1530/eje.1.02114
Sterkenburg AS, Hoffmann A, Gebhardt U, Warmuth-Metz M, Daubenbuchel AM, Muller HL (2015) Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes. Neuro Oncol 17:1029–1038. https://doi.org/10.1093/neuonc/nov044
Muller HL (2010) Increased daytime sleepiness in patients with childhood craniopharyngioma and hypothalamic tumor involvement: review of the literature and perspectives. Int J Endocrinol 2010:519607 https://doi.org/10.1155/2010/519607
Laffond C, Dellatolas G, Alapetite C, Puget S, Grill J, Habrand JL, Doz F, Chevignard M (2012) Quality-of-life, mood and executive functioning after childhood craniopharyngioma treated with surgery and proton beam therapy. Brain Inj 26:270–281. https://doi.org/10.3109/02699052.2011.648709
Marin RS (1990) Differential diagnosis and classification of apathy. Am J Psychiatry 147:22–30. https://doi.org/10.1176/ajp.147.1.22
Weitzner MA (1998) Neuropsychiatry and pituitary disease: an overview. Psychother Psychosom 67:125–132
Weitzner MA, Kanfer S, Booth-Jones M (2005) Apathy and pituitary disease: it has nothing to do with depression. J Neuropsychiatry Clin Neurosci 17:159–166. https://doi.org/10.1176/jnp.17.2.159
Fox ME, King TZ (2016) Pituitary disorders as a predictor of apathy and executive dysfunction in adult survivors of childhood brain tumors. Pediatric Blood Cancer 63:2019–2025. https://doi.org/10.1002/pbc.26144
Marin RS (1991) Apathy: a neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci 3:243–254. https://doi.org/10.1176/jnp.3.3.243
Starkstein SE, Petracca G, Chemerinski E, Kremer J (2001) Syndromic validity of apathy in Alzheimer’s disease. Am J Psychiatry 158:872–877. https://doi.org/10.1176/appi.ajp.158.6.872
Robert P, Onyike CU, Leentjens AFG, Dujardin K, Aalten P, Starkstein S, Verhey FRJ, Yessavage J, Clement JP, Drapier D, Bayle F, Benoit M, Boyer P, Lorca PM, Thibaut F, Gauthier S, Grossberg G, Vellas B, Byrne J (2009) Proposed diagnostic criteria for apathy in Alzheimer’s disease and other neuropsychiatric disorders. Eur Psychiatry 24:98–104. https://doi.org/10.1016/j.eurpsy.2008.09.001
Resnick B, Zimmerman SI, Magaziner J, Adelman A (1998) Use of the apathy evaluation scale as a measure of motivation in elderly people. Rehabilit Nurs 23:141–147. https://doi.org/10.1002/j.2048-7940.1998.tb01766.x
van Reekum R, Stuss DT, Ostrander L (2005) Apathy: why care? J Neuropsychiatry Clin Neurosci 17:7–19. https://doi.org/10.1176/jnp.17.1.7
Marin RS, Firinciogullari S, Biedrzycki RC (1993) The sources of convergence between measures of apathy and depression. J Affect Disord 28:117–124
Levy ML, Cummings JL, Fairbanks LA, Masterman D, Miller BL, Craig AH, Paulsen JS, Litvan I (1998) Apathy is not depression. J Neuropsychiatry Clin Neurosci 10:314–319. https://doi.org/10.1176/jnp.10.3.314
Marin RS, Firinciogullari S, Biedrzycki RC (1994) Group differences in the relationship between apathy and depression. J Nerv Ment Dis 182:235–239
Moretti R, Signori R (2016) Neural correlates for apathy: frontal-prefrontal and parietal cortical- subcortical circuits. Front Aging Neurosci 8:289. https://doi.org/10.3389/fnagi.2016.00289
Le Heron C, Apps MAJ, Husain M (2017) The anatomy of apathy: a neurocognitive framework for amotivated behaviour. Neuropsychologia https://doi.org/10.1016/j.neuropsychologia.2017.07.003
Hua C, Shulkin BL, Indelicato DJ, Li Y, Li X, Boop FA, Merchant TE (2015) Postoperative cerebral glucose metabolism in pediatric patients receiving proton therapy for craniopharyngioma. J Neurosurg 16:567–573 https://doi.org/10.3171/2015.4.PEDS159
Ozyurt J, Muller HL, Warmuth-Metz M, Thiel CM (2017) Hypothalamic tumors impact gray and white matter volumes in fronto-limbic brain areas. Cortex 89:98–110. https://doi.org/10.1016/j.cortex.2017.01.017
Marin RS, Biedrzycki RC, Firinciogullari S (1991) Reliability and validity of the Apathy evaluation scale. Psychiatry Res 38:143–162
Lueken U, Seidl U, Schwarz M, Volker L, Naumann D, Mattes K, Schroder J, Schweiger E (2006) Psychometric properties of a German version of the apathy evaluation scale. Fortschr Neurol Psychiatr 74:714–722. https://doi.org/10.1055/s-2006-932164
Hautzinger M, Bailer M, Hofmeister D, Keller F (2012) Allgemeine depressionsskala. Hogrefe, Göttingen
Radloff LS (1977) The CES-D scale—a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401 doi. https://doi.org/10.1177/014662167700100306
Smets EM, Garssen B, Bonke B, De Haes JC (1995) The Multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39:315–325
Schwarz R, Krauss O, Hinz A (2003) Fatigue in the general population. Onkologie 26:140–144 doi:69834
Kuhnt S, Ernst J, Singer S, Ruffer JU, Kortmann RD, Stolzenburg JU, Schwarz R (2009) Fatigue in cancer survivors-prevalence and correlates. Onkologie 32:312–317. https://doi.org/10.1159/000215943
Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540–545
Sander C, Hegerl U, Wirkner K, Walter N, Kocalevent RD, Petrowski K, Glaesmer H, Hinz A (2016) Normative values of the Epworth sleepiness scale (ESS), derived from a large German sample. Sleep Breath 20:1337–1345. https://doi.org/10.1007/s11325-016-1363-7
Bloch KE, Schoch OD, Zhang JN, Russi EW (1999) German version of the Epworth sleepiness scale. Respiration 66:440–447. https://doi.org/10.1159/000029408
Handwerker G (2007) Narkolepsie. Monatsschr Kinderheilkd 155:624–629
Wolff JE, Daumling E, Dirksen A, Dabrock A, Hartmann M, Jurgens H (1996) Munster Heidelberg abilities scale—a measuring instrument for global comparison of illness sequelae. Klin Padiatr 208:294–298. https://doi.org/10.1055/s-2008-1046486
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376
Schwarz R, Hinz A (2001) Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 37:1345–1351
Hoffmann A, Warmth-Metz M, Gebhardt U, Pietsch T, Pohl F, Kortmann RD, Calaminus G, Muller HL (2014) Childhood craniopharyngioma—changes of treatment strategies in the trials KRANIOPHARYNGEOM 2000/2007. Klin Padiatr 226:161–168. https://doi.org/10.1055/s-0034-1368785
Muller HL, Bueb K, Bartels U, Roth C, Harz K, Graf N, Korinthenberg R, Bettendorf M, Kuhl J, Gutjahr P, Sorensen N, Calaminus G (2001) Obesity after childhood craniopharyngioma-German multicenter study on pre-operative risk factors and quality of life. Klin Padiatr 213:244–249. https://doi.org/10.1055/s-2001-16855
Rolland-Cachera MF, Cole TJ, Sempe M, Tichet J, Rossignol C, Charraud A (1991) Body Mass Index variations: centiles from birth to 87 years. Eur J Clin Nutr 45:13–21
Muller HL, Gebhardt U, Teske C, Faldum A, Zwiener I, Warmuth-Metz M, Pietsch T, Pohl F, Sorensen N, Calaminus G, Study Committee of K (2011) Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up. Eur J Endocrinol 165:17–24. https://doi.org/10.1530/EJE-11-0158
Muller HL, Gebhardt U, Faldum A, Warmuth-Metz M, Pietsch T, Pohl F, Calaminus G, Sorensen N (2012) Xanthogranuloma, Rathke’s cyst, and childhood craniopharyngioma: results of prospective multinational studies of children and adolescents with rare sellar malformations. J Clin Endocrinol Metab 97:3935–3943. https://doi.org/10.1210/jc.2012-2069
Radakovic R, Harley C, Abrahams S, Starr JM (2015) A systematic review of the validity and reliability of apathy scales in neurodegenerative conditions. Int Psychogeriatr 27:903–923. https://doi.org/10.1017/S1041610214002221
Poretti A, Grotzer MA, Ribi K, Schonle E, Boltshauser E (2004) Outcome of craniopharyngioma in children: long-term complications and quality of life. Dev Med Child Neurol 46:220–229
Levi RB, Drotar D (1999) Health-related quality of life in childhood cancer: discrepancy in parent-child reports. Int J Cancer Suppl 12:58–64
Heinks K, Boekhoff S, Hoffmann A, Warmuth-Metz M, Eveslage M, Peng J, Calaminus G, Muller HL (2018) Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007. Endocrine 59:364–372. https://doi.org/10.1007/s12020-017-1489-9
Canning EH, Canning RD, Boyce WT (1992) Depressive symptoms and adaptive style in children with cancer. J Am Acad Child Adolesc Psychiatry 31:1120–1124. https://doi.org/10.1097/00004583-199211000-00021
Grace J, Malloy P (2001) The frontal systems behavior scale manual. Psychological Assessment Resources, Odessa
Drijgers RL, Verhey FR, Leentjens AF, Kohler S, Aalten P (2011) Neuropsychological correlates of apathy in mild cognitive impairment and Alzheimer’s disease: the role of executive functioning. Int Psychogeriatr 23:1327–1333. https://doi.org/10.1017/S1041610211001037
Balazs J, Miklosi M, Kereszteny A, Hoven CW, Carli V, Wasserman C, Apter A, Bobes J, Brunner R, Cosman D, Cotter P, Haring C, Iosue M, Kaess M, Kahn JP, Keeley H, Marusic D, Postuvan V, Resch F, Saiz PA, Sisask M, Snir A, Tubiana A, Varnik A, Sarchiapone M, Wasserman D (2013) Adolescent subthreshold-depression and anxiety: psychopathology, functional impairment and increased suicide risk. J Child Psychol Psychiatry 54:670–677. https://doi.org/10.1111/jcpp.12016
Zenker S, Haverkamp F, Klingmuller D (2002) Growth hormone deficiency in pituitary disease: relationship to depression, apathy and somatic complaints. Eur J Endocrinol 147:165–171
Mortby ME, Maercker A, Forstmeier S (2012) Apathy: a separate syndrome from depression in dementia? A critical review. Aging Clin Exp Res 24:305–316. https://doi.org/10.3275/8105
Duffy J (2000) Apathy in neurologic disorders. Current Psychiatry Rep 2:434–439. https://doi.org/10.1007/s11920-000-0029-z
Thobois S, Prange S, Sgambato-Faure V, Tremblay L, Broussolle E (2017) Imaging the etiology of apathy, anxiety, and depression in Parkinson’s disease: implication for treatment. Curr Neurol Neurosci Rep 17:76. https://doi.org/10.1007/s11910-017-0788-0
Skorvanek M, Gdovinova Z, Rosenberger J, Saeedian RG, Nagyova I, Groothoff JW, van Dijk JP (2015) The associations between fatigue, apathy, and depression in Parkinson’s disease. Acta Neurol Scand 131:80–87. https://doi.org/10.1111/ane.12282
Carroll C, Watson P, Spoudeas HA, Hawkins MM, Walker DA, Clare IC, Holland AJ, Ring HA (2013) Prevalence, associations, and predictors of apathy in adult survivors of infantile (< 5 years of age) posterior fossa brain tumors. Neuro Oncol 15:497–505. https://doi.org/10.1093/neuonc/nos320
Ailion AS, Hortman K, King TZ (2017) Childhood brain tumors: a systematic review of the structural neuroimaging literature. Neuropsychol Rev 27:220–244. https://doi.org/10.1007/s11065-017-9352-6
Zhang Y, Zou P, Mulhern RK, Butler RW, Laningham FH, Ogg RJ (2008) Brain structural abnormalities in survivors of pediatric posterior fossa brain tumors: a voxel-based morphometry study using free-form deformation. Neuroimage 42:218–229. https://doi.org/10.1016/j.neuroimage.2008.04.181
Muller HL, Gebhardt U, Teske C, Faldum A, Zwiener I, Warmuth-Metz M, Pietsch T, Pohl F, Sorensen N, Calaminus G (2011) Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up. Eur J Endocrinol 165:17–24. https://doi.org/10.1530/EJE-11-0158
Acknowledgements
The authors would like to acknowledge Saskia Sauer for helping in the collection and analysis of data.
Disclosure
The authors have no financial relationships relevant to this article to disclose.
Funding
This work was funded by a Grant (DKS2014.13) of the German Childhood Cancer Foundation, Bonn, Germany and a Grant (Forschungspool) of the European Medical School, Oldenburg, Germany.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to disclose.
Rights and permissions
About this article
Cite this article
Mehren, A., Özyurt, J., zu Klampen, P. et al. Self- and informant-rated apathy in patients with childhood-onset craniopharyngioma. J Neurooncol 140, 27–35 (2018). https://doi.org/10.1007/s11060-018-2936-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-018-2936-z